Related Experiment Video
Updated: May 1, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Successful treatment of cutaneous small-vessel vasculitis with upadacitinib: a Case Report
Xingmo Li1,2,3, Zhuochen Wu1,2,3, Xin Zhao1,2,3
1Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Abstract:
Cutaneous small-vessel vasculitis (CSVV) is a rare skin vasculitis that mainly affects small blood vessels and is often caused by certain drugs or diseases. When the condition is severe, skin ulcers may occur, accompanied by severe pain, which can affect daily life. This article reports a case in which the patient had a poor response to conventional corticosteroid therapy, with the condition continuing to deteriorate. Following 3 months of combination therapy with oral upadacitinib, the skin lesions nearly healed completely. This provides a new perspective for the treatment of CSVV and offers clinicians an additional treatment option.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
